Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Endocrine 2

Conditions

Melanoma 30Neoplasms 11Thyroid Neoplasms 7Thyroid Carcinoma, Anaplastic 6Brain Neoplasms 6Multiple Myeloma 4Glioma 4Colorectal Neoplasms 4Hematologic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Thyroid Cancer, Papillary 2Skin Neoplasms 2Neoplasm Metastasis 2Lymphoma 2Glioblastoma 2Astrocytoma 2Ameloblastoma 2Adenocarcinoma, Follicular 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid cancer, follicular 1Thyroid cancer, Hurthle cell 1Stomach Neoplasms 1Spinocerebellar Degenerations 1Solid Tumor 1Rectal Neoplasms 1Rare Malignant Neoplasm 1Prostatic Neoplasms 1Pancreatic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 8Iodine-131 5trametinib 3lenvatinib 3Thyrotropin Alfa 3Sunitinib 3Specimen Handling 3Fluorodeoxyglucose F18 32-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3dabrafenib 2cabozantinib 2X-Rays 2Sorafenib 2Radiotherapy 2Everolimus 2vandetanib 1tremelimumab 1tanespimycin 1spartalizumab 1selpercatinib 1sargramostim 1romidepsin 1pembrolizumab 1omipalisib 1motesanib diphosphate 1durvalumab 1cobimetinib 1aldesleukin 1aflibercept 1Vorinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Adenocarcinoma, Follicular × dabrafenib × Clear all
NCT04544111 2025-10-07

PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
19 enrolled
EndocrineHead & Neck

Thyroid cancer, Hurthle cell, Thyroid cancer, follicular, Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenoma, Oxyphilic, Adenocarcinoma, Follicular

NCT01723202 2025-08-24

Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Completed
53 enrolled 11 charts
EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡